Zacks: Clinigen Group Plc (CLIGF) Given Consensus Rating of “Strong Buy” by Analysts
Clinigen Group Plc (NASDAQ:CLIGF) has been given an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.
Zacks has also assigned Clinigen Group Plc an industry rank of 167 out of 265 based on the ratings given to related companies.
Separately, Zacks Investment Research cut Clinigen Group Plc from a “buy” rating to a “hold” rating in a report on Wednesday, May 24th.
Shares of Clinigen Group Plc (CLIGF) opened at 12.90 on Tuesday. Clinigen Group Plc has a 1-year low of $8.50 and a 1-year high of $13.00. The firm has a market cap of $1.48 billion and a PE ratio of 79.63.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Clinigen Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.